Taiwan FDA registration f17aca47c81347377174c7e54efdf02e

Zeus nuclear antigen enzyme linked immunoassay screening system

TW: 宙斯核抗原酵素連接免疫分析篩檢系統

Taiwan·Risk Class 2·ZEUS SCIENTIFIC, INC.·Registered May 04, 2012 – May 04, 2027Active

Registration details

Analysis ID: f17aca47c81347377174c7e54efdf02e
Customs Code: DHA00602346801

Company information

Manufacturer: ZEUS SCIENTIFIC, INC.
Manufacturer Country: United States
Authorized Representative: TRUGENE DIAGNOSTICS, INC.

Product details

Intended Use: The immunoenzyme method (ELISA) is used to qualitatively detect antibodies corresponding to extractable nuclear antigens (ENA) in human serum.
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.5100 抗核抗體免疫試驗系統
Import Information: import

Dates and status

Registration Date: May 04, 2012
Expiry Date: May 04, 2027

About this record

Access comprehensive regulatory information for Zeus nuclear antigen enzyme linked immunoassay screening system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f17aca47c81347377174c7e54efdf02e and manufactured by ZEUS SCIENTIFIC, INC.. The authorized representative in Taiwan is TRUGENE DIAGNOSTICS, INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.